U.S. Markets open in 4 hrs 3 mins

FDA approves Sarepta's muscular dystrophy drug

Sarepta soared after the company gained FDA approval for its muscular dystrophy treatment. Yahoo Finance’s Anjalee Khemlani joins Seana Smith on The Ticker to discuss.